Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model (2007)
- Authors:
- USP affiliated authors: FERNANDES, BIANCA HELENA VENTURA - FM ; FUJIHARA, CLARICE KAZUE - FM ; ZATZ, ROBERTO - FM
- Unidade: FM
- Subjects: NEFROPATIAS; MODELOS ANIMAIS; RATOS; RESUMOS (SIMPÓSIOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio avanços em pesquisas médicas
-
ABNT
COSTA, S. R. et al. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 mar. 2024. , 2007 -
APA
Costa, S. R., Sena, C. R., Fernandes, B. H. V., Carvalho, L. de F., Malheiros, D. M. A. C., Zatz, R., & Fujihara, C. K. (2007). Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Costa SR, Sena CR, Fernandes BHV, Carvalho L de F, Malheiros DMAC, Zatz R, Fujihara CK. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. 2007 ; 62 S39.[citado 2024 mar. 29 ] -
Vancouver
Costa SR, Sena CR, Fernandes BHV, Carvalho L de F, Malheiros DMAC, Zatz R, Fujihara CK. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. 2007 ; 62 S39.[citado 2024 mar. 29 ] - Combined Losartan (L) and Hydrocholorothyazide (H) treatment (LH) prevents progression of chronic kidney disease (CKD) resulting from L treatment during lactation (LLac)
- Regressão da nefropatia diabética experimental: Ausência de efeito dose resposta de um antagonista da angiotensina II
- Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist
- High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac)
- Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm)
- Agravamento por anormalidades sericas da esclerose glomerular em ratos analbuminemicos com nefrectomia subtotal
- Dinamica da ultrafiltracao glomerular no rato analbuminemico
- Reatividade vascular renal na diabetes mellitus (DM) experimental: efeito da insulinoterapia (IT)
- Dose-dependent renal protective effect of late losartan treatmente in the remannt kidney model
- Cyclooxygenase-2 inhibitors: will they help us prevent diabetic nephropathy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas